A new, faster, and more cost-effective molecular diagnostic tool, Intelli-OVI, has been developed. It offers the potential for continuous monitoring of emerging SARS-CoV-2 variants and provides an ...
Invivyd, Inc. has announced new in vitro data showing that its monoclonal antibody PEMGARDA™ (pemivibart) maintains effective neutralizing activity against the prevalent LP.8.1 variant of SARS-CoV-2, ...
A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...
At the L.A. County Sentinel Surveillance Laboratories, 12.6% of specimens tested positive for SARS-CoV-2, according to the Los Angeles County Department of Public Health. This rise in positive cases ...
A Stanford-led team has found two antibodies that can work together to defeat all SARS-CoV-2 variants. More research is needed, but the approach could help in the development of treatments to keep ...
Harnessing the power of a single dose, this innovative vaccine offers a potent defense against both current and future COVID-19 threats. Study: A single-dose intranasal live-attenuated codon ...
Invivyd, Inc. (Nasdaq: IVVD) today announced a peer-reviewed publication by Invivyd that uses data from the recent CANOPY pivotal clinical trial of Invivyd’s monoclonal antibody pemivibart to predict ...
CDC data show SARS-CoV-2 and RSV continue to impact younger children and older adults, with significant hospitalization and mortality rates across the US.
3y
Covid-19
Read Latest News on Covid 19 along with top headlines and breaking news today. Also get Covid 19 Updates, Photos and Videos at Hindustan Times ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results